In The News
ConstructionPRO Test 1
ConstructionPRO Test 2
ConstructionPRO Test 3
ConstructionPRO Test 4
ConstructionPRO Test 5
ConstructionPRO Test 6
ConstructionPRO Test 7
High Court rejects Qantas appeal in ground crew sacking case
I’m afraid AI can’t do that: Law firms say smart tech uses limited
Lawyer’s defamation case fails serious harm test, judge finds
Bristol-Myers Squibb denies claims in Merck Sharp & Dohme’s misuse of market power case
Bristol-Myers Squibb 2021-08-06 3:06 pm By Miklos Bolza Sydney
Please login to bookmark Close

Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival’s claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au